Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry
Launched by CMC AMBROISE PARÉ · Jul 4, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Registry for the Improvement of Postoperative Outcomes in Cardiac and Thoracic Surgery, is focused on understanding how different factors before and during surgery can affect recovery after heart or lung surgery. Researchers are collecting information on various patient characteristics and surgical details to see how they relate to outcomes like complications, the need for additional surgeries, or serious events like sepsis and shock.
If you or a loved one is eligible for cardiac or thoracic surgery, you could participate in this study. There are no specific exclusions, meaning anyone who is set to undergo these types of surgeries can join. Participants will help contribute valuable information that may improve future surgical care. It's an opportunity to be part of something that could lead to better outcomes for patients in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients eligible for cardiac or thoracic surgery
- Exclusion Criteria:
- • non applicable
About Cmc Ambroise Paré
CMC Ambroise Paré is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on enhancing patient care, the organization specializes in the development and management of clinical trials across various therapeutic areas. CMC Ambroise Paré is committed to rigorous scientific standards, ensuring compliance with regulatory requirements while fostering collaboration among healthcare professionals, researchers, and stakeholders. By leveraging cutting-edge methodologies and a patient-centric approach, the organization aims to contribute to the development of safe and effective treatments, ultimately improving health outcomes and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Neuilly Sur Seine, Ile De France, France
Patients applied
Trial Officials
Marie-Caroline Merand
Study Chair
CMC Ambroise Paré
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials